Home / Share Price Target / Krebsbio
Krebs Biochemicals & Share Price Target 2024, 2025, 2026 to 2039 With Charts
Krebs Biochemicals & Industries Limited | |||
 | Symbol: KREBSBIO | ||
| Price: ₹97.79 | |||
| Exchange: NSE | |||
| Healthcare -> Drug Manufacturers—Specialty & Generic | |||
Show Table of Contents
Table of Contents
- 1: Krebs Biochemicals & Brief Company Overview
- 1.1: Krebs Biochemicals & Industries Limited: A Trusted Partner in Pharmaceutical Innovation
- 1.2: Krebs Biochemicals & Financial Performance
- 1.2.1: Is Krebs Biochemicals & A Good Buy For Long Term?
- 2: Approach 1: Technical Analysis Paired With Price Action
- 2.1: Krebs Biochemicals & Share Price Target For 2024
- 2.1.1: Krebs Biochemicals & Share Price Target Table For 2024
- 2.1.2: Summary: Krebs Biochemicals & Share Price Prediction For 2024
- 2.2: Krebs Biochemicals & Share Price Target For 2025
- 2.2.1: Krebs Biochemicals & Share Price Target Table For 2025
- 2.2.2: Summary: Krebs Biochemicals & Share Price Prediction For 2025
- 3: Approach 2: Machine Learning By Studying Historical Prices
- 3.1: Krebs Biochemicals & Long Term Share Price Prediction Chart From 2024, 2025, 2026 to 2039
- 3.2: Krebs Biochemicals & Share Price Target Table From 2024, 2025, 2026 to 2039
- 4: Krebs Biochemicals & Past Performance
Krebs Biochemicals & Brief Company Overview
Krebs Biochemicals & Industries Limited: A Trusted Partner in Pharmaceutical Innovation
Established in 1991 and headquartered in Hyderabad, India, Krebs Biochemicals & Industries Limited is a leading manufacturer of active pharmaceutical ingredients (APIs) catering to the Indian healthcare industry. With over three decades of experience, the company has built a solid reputation for its commitment to quality, innovation, and customer satisfaction.
Key Products and Services:- Manufacturing and sale of APIs for anti-cholesterol and steroid intermediate applications
- Development of biotech processes for various industries
- Contract manufacturing services for large pharmaceutical and multinational companies
- Androstenedione
- Lovastatin
- Simvastatin
- Amlodipine
- Cetirizine
- Orlistat
- Serratiopeptidase
- Telmisartan
- Phenylephrine
Krebs Biochemicals & Financial Performance
| Metric | Value | Description |
|---|---|---|
| Market Capital | 183.65 Crore | Market valuation of Krebs Biochemicals &'s shares. |
| Revenue (TTM) | 52.72 Crore | Total revenue generated by Krebs Biochemicals & over the past twelve months. |
| Net Income (TTM) | -19.56 Crore | Net Profit or Loss after all the expenses over the past twelve months. |
| Operating Margin | -29.9% | Income from operations as a percentage of revenue, before taxes and interest. |
| Profit Margin | -37.11% | Net income as a percentage of revenue, after all expenses. |
| Revenue Growth (Quarterly) | +21.8% | Change in revenue compared to the previous quarter. |
| Debt-to-Equity (D/E) Ratio | -1.63 | Company's total debt divided by total shareholder equity. |
| Total Debt | 193.42 Crore | Sum of Krebs Biochemicals &'s current & long-term financial obligations. |
| Total Cash | 13.74 Lakh | Total amount of liquid funds available to Krebs Biochemicals &. |
| Beta | 0.45 | Beta is less than 1 indicating that the Krebs Biochemicals &'s price is less volatile than the market. |
Is Krebs Biochemicals & A Good Buy For Long Term?
No valid response content found
To predict the Krebs Biochemicals &'s future market prices, we harnessed 2 dynamic approaches:
Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices
Approach 1: Technical Analysis Paired With Price Action
Krebs Biochemicals & Share Price Target For 2024
The line chart displays the monthly closing prices of Krebs Biochemicals & with a black line. The green line shows three potential target prices for 2024, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Krebs Biochemicals & shares in 2024, see the table below.
Krebs Biochemicals & Share Price Target Table For 2024
| Krebs Biochemicals &'s Levels | Value | Reason/Importance |
|---|---|---|
| 2024 Target 3 | 102.49 (+4.8%) | Price Action: Aug 1999 Low |
| 2024 Target 2 | 101.42 (+3.71%) | Price Action: Dec 2017 Low |
| 2024 Target 1 | 100.36 (+2.62%) | Price Action: Nov 2001 High |
| Current Price | 97.79 | Krebs Biochemicals &'s 1 share price as of Mon 25 Nov 2024 |
| Stop Loss 1 | 96.59 (-1.23%) | Price Action: Sep 1995 High |
| Stop Loss 2 | 95.58 (-2.26%) | Price Action: Sep 2017 High |
| Stop Loss 3 | 93.95 (-3.93%) | Price Action: Nov 2023 High |
Summary: Krebs Biochemicals & Share Price Prediction For 2024
In summary, Krebs Biochemicals & has surged by ₹19.44, achieving a notable +24.81% increase from 1st January 2024 to 25 Nov 2024. Our analysis of Krebs Biochemicals & for 2024 predicts an additional rise of 2.62% to 4.8% by the end of 2024 with three potential targets T1: 100.36, T2: 101.42, T3: 102.49. Stop Loss at SL1: 96.59, SL2: 95.58, SL3: 93.95.
Krebs Biochemicals & has a 52-week high of ₹121.55, acting as a crucial resistance level - a ceiling that could challenge further price increase. Conversely, it has a 52-week low of ₹60.35, a critical support level - think of this as a safety net where the price might stop falling.
After looking at 2024's share price prediction, let's now check what 2025 might hold for Krebs Biochemicals &.
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Krebs Biochemicals & Share Price Target For 2025
The line chart displays the monthly closing prices of Krebs Biochemicals & with a black line. The green line shows three potential target prices for 2025, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Krebs Biochemicals & shares in 2025, see the table below.
Krebs Biochemicals & Share Price Target Table For 2025
| Krebs Biochemicals &'s Levels | Value | Reason/Importance |
|---|---|---|
| 2025 Target 3 | 126.34 (+29.19%) | Fibonacci Extension Level 171.8% |
| 2025 Target 2 | 123.95 (+26.75%) | Price Action: Chart |
| 2025 Target 1 | 122.72 (+25.49%) | Custom Fibonacci Extension Lvl 64.9% |
| Current Price | 97.79 | Krebs Biochemicals &'s 1 share price as of Mon 25 Nov 2024 |
| Stop Loss 1 | 92.05 (-5.87%) | Price Action: May 1997 High |
| Stop Loss 2 | 91.00 (-6.95%) | Price Action: Apr 2019 Low |
| Stop Loss 3 | 89.74 (-8.24%) | Price Action: Aug 2000 High |
Summary: Krebs Biochemicals & Share Price Prediction For 2025
In summary, Krebs Biochemicals & has surged by ₹19.44, achieving a notable +24.81% increase from 1st January 2024 to 25 Nov 2024. Our analysis of Krebs Biochemicals & for 2025 predicts an additional rise of 25.49% to 29.19% by the end of 2025 with three potential targets T1: 122.72, T2: 123.95, T3: 126.34. Stop Loss at SL1: 92.05, SL2: 91.00, SL3: 89.74.
Krebs Biochemicals & has a All-Time high of ₹227.89, acting as a crucial resistance level - a ceiling that could challenge further price increase. Conversely, it has a 52-week low of ₹60.35, a critical support level - think of this as a safety net where the price might stop falling.
After looking at 2024's and 2025's share price prediction, you might wonder what are short term targets for Krebs Biochemicals &, we have created a specific page for that check here: Krebs Biochemicals & Share Price Target For Tomorrow & Next Week
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Approach 2: Machine Learning By Studying Historical Prices
Krebs Biochemicals & Long Term Share Price Prediction Chart From 2024, 2025, 2026 to 2039
This chart presents a detailed projection of Krebs Biochemicals & share price predictions from 2024, 2025, 2026 to 2039. This share price Prediction represents a CAGR of 10.46% over the next 15 years.
For complete year by year Krebs Biochemicals & long term share price target from 2024, 2025 to 2039 check the below table.
Krebs Biochemicals & Share Price Target Table From 2024, 2025, 2026 to 2039
| Year | Krebs Biochemicals & Target | YoY Change % |
|---|---|---|
| 2024 | ₹97.79 | [Current Price] |
| 2024 | ₹80.16 | -18.03% |
| 2025 | ₹107.35 | 33.91% |
| 2026 | ₹135.35 | 26.08% |
| 2027 | ₹152.03 | 12.32% |
| 2028 | ₹161.43 | 6.18% |
| 2029 | ₹170.12 | 5.38% |
| 2030 | ₹205.73 | 20.93% |
| 2031 | ₹240.17 | 16.74% |
| 2032 | ₹253.99 | 5.75% |
| 2033 | ₹256.88 | 1.13% |
| 2034 | ₹260.07 | 1.24% |
| 2035 | ₹304.1 | 16.93% |
| 2036 | ₹345 | 13.44% |
| 2037 | ₹355.94 | 3.17% |
| 2038 | ₹352.33 | -1.02% |
| 2039 | ₹322.63 | -8.43% |
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Krebs Biochemicals & Past Performance
- In 1995, Krebs Biochemicals & opening price was ₹93.7
- As of Mon 25 Nov 2024 the price stands at ₹97.79.
- This represents a Compound Annual Growth Rate (CAGR) of 0.14%.
- In 29 years, an investment of 10,000 would have become ₹10,436.49.
As we wrap up, we hope you like our study on Krebs Biochemicals & share price predictions, please kindly note that these forecasts are based on technical analysis, past trends, and machine learning models. They are for educational purposes only, not investment advice.
Show Methodology We Use
Methodology Behind the Prediction
The share price predictions present on our site are derived from a robust model that incorporates multiple economic indicators, technical indicators, company performance metrics, and industry-specific factors.
We have historical share price data of all stocks for which we present targets, so we analyse historical trends from those past data and overlay them with projected market conditions to estimate future share prices of a stock.
Disclaimer: Information is provided 'as is' and solely for informational and educational purposes, not for trading purposes or advice. We highly recommend to do your own research before making any investment.
